Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

29.79USD
3:50pm EDT
Change (% chg)

$0.96 (+3.33%)
Prev Close
$28.83
Open
$28.86
Day's High
$30.39
Day's Low
$28.73
Volume
196,094
Avg. Vol
135,984
52-wk High
$30.39
52-wk Low
$13.20

DVAX.OQ

Chart for DVAX.OQ

About

Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company. The Company uses toll-like receptor (TLR) biology to discover and develop vaccines and therapeutics. Its development programs are organized under three areas of focus: vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory... (more)

Overall

Beta: 3.10
Market Cap(Mil.): $964.97
Shares Outstanding(Mil.): 33.47
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 434.54 39.84
EPS (TTM): -3.89 -- --
ROI: -76.58 -5.70 15.61
ROE: -82.84 -5.69 16.64
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks